triclabendazole has been researched along with Infections, Staphylococcal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Cheng, H; Deng, Q; Guo, J; Li, D; Wang, Z; Wen, Z; Yu, Z; Zhang, Y | 1 |
1 other study(ies) available for triclabendazole and Infections, Staphylococcal
| Article | Year |
|---|---|
Inhibition of Staphylococcus aureus and biofilm formation by the anthelminthic drug, triclabendazole.
Topics: Anti-Bacterial Agents; Biofilms; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Proteomics; Staphylococcal Infections; Staphylococcus aureus; Triclabendazole | 2022 |